Terms: = Gastric cancer AND IL6ST, CDw130, 3572, ENSG00000134352, P40189, IL6R-beta, GP130-RAPS, GP130, CD130 AND Staging
3 results:
1. Glycoprotein 130 is associated with adverse postoperative clinical outcomes of patients with late-stage non-metastatic gastric cancer.
Cao Y; Zhang H; Liu H; Lin C; Li R; Wu S; He H; Li H; Xu J
Sci Rep; 2016 Dec; 6():38364. PubMed ID: 27917904
[TBL] [Abstract] [Full Text] [Related]
2. IL-6 and IL-11 as markers for tumor aggressiveness and prognosis in gastric adenocarcinoma patients without mutations in gp130 subunits.
Necula LG; Chivu-Economescu M; Stanciulescu EL; Bleotu C; Dima SO; Alexiu I; Dumitru A; Constantinescu G; Popescu I; Diaconu CC
J Gastrointestin Liver Dis; 2012 Mar; 21(1):23-9. PubMed ID: 22457856
[TBL] [Abstract] [Full Text] [Related]
3. Adenocarcinoma of the stomach: autopsy observations with therapeutic implications for the radiation oncologist.
Wisbeck WM; Becher EM; Russell AH
Radiother Oncol; 1986 Sep; 7(1):13-8. PubMed ID: 3775075
[TBL] [Abstract] [Full Text] [Related]
